Press release 📈 Stocks 🌍 China

MOYOM Biotech Brand Aphranel Sponsors 2026 MXGP Shanghai Event

MOYOM Biotech's aphranel brand gains visibility through a strategic partnership with the 2026 MXGP Shanghai, marking a push into sports-integrated marketing for its aesthetic product line.

🕐 1 min read

1 assets impacted. Net bias: 0 Bullish, 0 Bearish, 1 Neutral. Strongest signal: MOYOM Biotech → 2/10 (55% confidence).

📊 Affected Assets (1)

MOYOM Biotech
Neutral 🤖 55%
📅 Short-term 🌍 CN · Explicit

MOYOM Biotech's brand aphranel partnered as an official sponsor of MXGP Shanghai 2026, indicating marketing expansion but no financial terms were disclosed.

🎯 Key Takeaways

  • Aphranel served as an official partner for the 2026 MXGP Shanghai held in September.
  • The partnership highlights MOYOM Biotech's strategy to increase brand visibility for its regenerative aesthetics portfolio.
  • No financial terms were disclosed regarding the sponsorship agreement.

📝 Executive Summary

MOYOM Biotech's regenerative aesthetics brand, aphranel, served as an official partner for the 2026 FIM Motocross World Championship in Shanghai. The company utilized the high-profile sporting event to showcase its latest facial aesthetic solutions to a global audience.

❓ FAQ

What was MOYOM Biotech's role in the 2026 MXGP Shanghai?

MOYOM Biotech's brand, aphranel, acted as an official partner for the event, using the platform to promote its regenerative aesthetics products.